Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Rhodes

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Science Translational Medicine|August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSAScott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
Cancer Cell|June 10, 2008
The role of SPINK1 in ETS rearrangement-negative prostate cancersScott A Tomlins, Daniel R Rhodes, Jianjun Yu, et al.
Neoplasia (New York, N.Y.)|May 1, 2015
Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumorsDaniel H Hovelson, Andrew S McDaniel, Andi K Cani, et al.
Cancer Research Communications|July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 BenefitBenjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
JCO Precision Oncology|September 3, 2021
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor SamplesScott A Tomlins, Daniel H Hovelson, Jennifer M Suga, et al.
Communications Medicine|February 7, 2023
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefitScott A Tomlins, Nickolay A Khazanov, Benjamin J Bulen, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Science Translational Medicine|August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSAScott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
Cancer Cell|June 10, 2008
The role of SPINK1 in ETS rearrangement-negative prostate cancersScott A Tomlins, Daniel R Rhodes, Jianjun Yu, et al.
Neoplasia (New York, N.Y.)|May 1, 2015
Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumorsDaniel H Hovelson, Andrew S McDaniel, Andi K Cani, et al.
Cancer Research Communications|July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 BenefitBenjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
JCO Precision Oncology|September 3, 2021
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor SamplesScott A Tomlins, Daniel H Hovelson, Jennifer M Suga, et al.
Communications Medicine|February 7, 2023
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefitScott A Tomlins, Nickolay A Khazanov, Benjamin J Bulen, et al.
Pageof 5